Hospital Pharmacy Europe

Hospitalpharmacyeurope.com is a complimentary platform that supports the Hospital Pharmacy Europe (HPE) journal. Users can easily access the complete content of each issue online, allowing pharmacists to quickly find and read well-written articles on subjects that matter to them with just a click.

International, Trade/B2B

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#2212696

India

#256716

Health/Pharmacy

#253

Traffic sources

Monthly visitors

Articles

Clinical pharmacy leadership: a view from Scotland

2 weeks ago | hospitalpharmacyeurope.com | Helena Beer

As the NHS advances, effective clinical leadership in pharmacy is vital to improve the pharmaceutical care of patients. In Scotland, the Scottish Pharmacy Clinical Leadership Fellowship scheme aims to support just that, as Gerry Hughes finds out. The goal of the Scottish Pharmacy Clinical Leadership Fellowship, launched in 2018, is to nurture future pharmacy leaders and advance strategic healthcare goals in Scotland.
A decade of driving medicines optimisation innovation in clinical pharmacy

3 weeks ago | hospitalpharmacyeurope.com | Helena Beer

The Medicines Optimisation Innovation Centre (MOIC) in Northern Ireland has become a pivotal force in advancing healthcare, particularly in the essential field of medicines optimisation. In this case study, marking a decade since its inception, Katherine Redpath examines MOIC’s achievements, ongoing projects and future aspirations. The suboptimal use of medicines presents a significant global challenge1, resulting in adverse health outcomes, inefficiencies and considerable waste.
Early ezetimibe initiation after myocardial infarction significantly improves prognosis, study finds

3 weeks ago | hospitalpharmacyeurope.com | Helena Beer

Early combination lipid-lowering therapy with statins and ezetimibe significantly improves prognosis after myocardial infarction compared with later adding ezetimibe or not giving it at all, a study finds.
The essential role of hospital pharmacists in the CAR T-cell supply chain

4 weeks ago | hospitalpharmacyeurope.com | Helena Beer

As an overall patient safety and medicines quality measure, hospital pharmacists in Belgium have mitigated critical risks in the supply chain for chimeric antigen receptor (CAR) T-cell therapies. Advanced therapy medicinal products (ATMPs), such as CAR T-cell therapies, are innovative biological drugs that demand careful management of complex supply chains. In Belgium, licensing regulations mandate pharmacist oversight of these processes.
A pharmacist’s take on actions from the child asthma and anaphylaxis deaths report

1 month ago | hospitalpharmacyeurope.com | Ravijyot Saggu |Helena Beer

The National Child Mortality Database report on child deaths related to asthma and allergies was released in December 2024, providing sobering insights. Pharmacist Ravijyot Saggu offers an expert summary, emphasising key points from the thematic report and discussing necessary future actions.
New insights on blister-packaged oral oncolytic agents for adherence

1 month ago | hospitalpharmacyeurope.com | Helena Beer

Non-adherence can negatively impact medication treatment strategies, particularly among oncology patients, driving up treatment costs while potentially worsening clinical outcomes. Although oral oncolytics offer convenience, they arguably require greater patient engagement in remembering to take their treatment, often resulting in lower adherence compared to infused therapies. Chronic lymphocytic leukaemia (CLL) is increasingly managed with long-duration, targeted oral treatments.
Greener Pharmacy Guide and Toolkit launched by RPS to support sustainability

1 month ago | hospitalpharmacyeurope.com | Helena Beer

A digital self-assessment tool designed to help hospital pharmacy teams take practical action to support sustainability and reduce the environmental impact of pharmacy services, pharmaceutical care and medicines, while supporting patient care, has been launched by the Royal Pharmaceutical Society (RPS).
Lutetium theranostics: revolutionising personalised cancer care

1 month ago | hospitalpharmacyeurope.com | Helena Beer

Theranostics integrates diagnostic and therapeutic radiopharmaceuticals targeting the same molecular structures – delivering a ‘one-two punch’ for personalised cancer care. In his latest commentary, Professor Alain Astier discusses how the radionuclide 177Lu and 177Lu-based radioligands have gained traction in treating various conditions, including neuroendocrine tumours and metastatic prostate cancer.
Cutting the carbon costs of cytotoxic drug production

1 month ago | hospitalpharmacyeurope.com | Gerry Hughes |Helena Beer

A recent study assessing the carbon footprint of a hospital pharmacy’s cytotoxic drug production unit and its main sources of greenhouse gas (GHG) emissions has revealed potential areas for improvement to reduce its global warming impact. Global health authorities forecast an additional 250,000 annual deaths from climate change between 2030 and 2050. Rising temperatures and extreme weather events are driving higher rates of food- and water-borne illnesses, amongst other conditions.
AI toolkit for pharmacy practice launched by FIP

1 month ago | hospitalpharmacyeurope.com | Helena Beer

A new toolkit to support pharmacists when integrating artificial intelligence (AI) into daily practice has been launched by the International Pharmaceutical Federation (FIP). The toolkit for hospital, industry and community settings offers structured guidance on AI adoption.